NORTH PALM BEACH, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that it has received a written notification from NYSE Regulation confirming that the Company is back in compliance with all NYSE American LLC continued listing standards set forth in Part 10 of the NYSE American Company Guide. In a letter dated July 15, 2026, NYSE Regulation informed the Company that it has resolved the continued listing deficiency with respect to Section 1003(a)(i) and (ii) of the Company Guide, which had been referenced in the Exchange

EMJX Shifted from "Stress" to "Mixed" for Bitcoin Company Files Updated Investor Presentation Outlining Performance and Strategy Management to Host Fireside Chat Today at 10:30am ET NORTH PALM BEACH, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today reported paper-traded EMJX returns of 26% from February 11, 2026 to July 10, 2026. The EMJX model reads market regime across three states — Bull, Mixed, and Stress — updating every trading day with a forward read on where crypto is heading over roughly the next 30 days. That signal

NORTH PALM BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that Chief Executive Officer, Kent Cunningham, and President of EMJX and Head of Asset Management, Eric Jackson, will participate in a virtual Fireside Chat on Tuesday, July 14, 2026, to discuss recent developments, the completed EMJX acquisition, and vision for the future. SRX Global Fireside Chat Details Date: Tuesday, July 14, 2026Time: 10:30 a.m. ETModerator: Valter Pinto, Managing Director, KCSA Strategic CommunicationsPanelists: Kent Cunningh

NORTH PALM BEACH, Fla., July 09, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to 10 million shares of its common stock or up to 50% of its shares outstanding. The Company has allocated up to $20 million to repurchase its common stock until July 9, 2027. "With no debt, a strong cash position, and the current market value of our shares, we believe this share repurchase program

Approximately $40 million in cash and more than $15 million in short-term investment assets as of June 30, 20261 Estimated net asset value of approximately $60 million and no debt outstanding as of June 30, 2026¹ Approximately 19.5 million shares outstanding on post 1-for-60 split basis as of July 6, 20261 NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today provided shareholders with a preliminary update on certain balance sheet metrics and its capitalization structur

NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that the Board of Directors has approved a one-time cash dividend of $0.05 per share (approximately $1 million in the aggregate) on common stock outstanding to shareholders of record at the close of business on July 22, 2026 (the "Record Date"). The dividend will be paid on or about August 3, 2026 to shareholders of record on Record Date. "This special dividend reflects the strength of our investment strategy and our commitment to returning value direct

NORTH PALM BEACH, Fla., July 02, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced a strategic investment in Greenland Mines Ltd., a critical and precious minerals development company advancing a portfolio of strategic assets in Greenland. About Greenland MinesGreenland Mines Ltd. is a Nasdaq-listed critical and precious minerals development company advancing a portfolio of strategic assets in Greenland. The Company’s strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals

NORTH PALM BEACH, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that its Board of Directors has approved a consolidation of the Company's issued and outstanding common stock on a 60-to-1 basis (the "Share Consolidation"), to be effective July 6, 2026 (the "Effective Date"). On the Effective Date, every 60 shares of issued and outstanding common stock will be automatically combined into one share of common stock. The Company's common stock will continue to trade on the NYSE American under the existing symbol "SRXH" a

NORTH PALM BEACH, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX") today announced a strategic investment in ARMR Sciences, a clinical-stage biodefense company developing a platform of medical countermeasures against synthetic drugs, such as fentanyl. ARMR’s lead product, ARMR-100, recently announced it has successfully generated an anti-fentanyl immune response in humans and showed favorable safety data. This marks a critical milestone in the company's path toward demonstrating that this response can protect against fentanyl. ARMR-100 is being designed to work with the body to generate a protective immune response. The product, in a Phase 1/2

Company announces name change to SRX Global in conjunction with transaction closingCompany's stock to remain trading on the NYSE American ("NYSE") under ticker symbol "SRXH" NORTH PALM BEACH, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company", or "SRX") today announced it has completed the acquisition of EMJ Crypto Technologies, Inc. ("EMJX") and is launching its new AI-driven platform strategy, which will focus on driving returns for shareholders through the allocation of capital into high-conviction operating companies and assets. In conjunction with the transaction closing, the Company has changed its legal name and branding to SRX Global Inc

4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

8-K - SRX Global Inc. (0001471727) (Filer)

424B3 - SRX Global Inc. (0001471727) (Filer)

424B3 - SRX Global Inc. (0001471727) (Filer)

8-K - SRX Global Inc. (0001471727) (Filer)

8-K - SRX Global Inc. (0001471727) (Filer)

8-K - SRX Global Inc. (0001471727) (Filer)

S-8 - SRX Global Inc. (0001471727) (Filer)

8-K - SRX Global Inc. (0001471727) (Filer)

8-K - SRX Global Inc. (0001471727) (Filer)

DEFR14C - SRX Global Inc. (0001471727) (Filer)

TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b

TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current

TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.("SRx Canada") and certain of its subsidiaries obtained an Initial Order (the "Initial Order") in Canada under the federal Companies' Creditors Arrangement Act (the "CCAA" and SRx Canada's proceedings thereunder, the "CCAA Proceedings") from the Ontario Superior Court of Justice (Commercial List) (the "Court"). In connection with the Initial Order, the Court granted, among other relief: a stay of proceedings in favor of SRx Canadathe appointment of Grant Thornton Limited

TAMPA, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced the appointment of current President, Kent Cunningham, as CEO, and current CEO, Adesh Vora, as Vice Chairman effective immediately. About SRx Health Solutions, Inc. SRx Health Solutions Inc. is an integrated Canadian healthcare services provider that operates within the specialty healthcare industry. The SRx network extends across all ten Canadian provinces, making it one of the most accessible providers of comprehensive, integrated, and customized specialty healthcare services in the country. SRx combines years of industry kn

NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that the Board of Directors has approved a one-time cash dividend of $0.05 per share (approximately $1 million in the aggregate) on common stock outstanding to shareholders of record at the close of business on July 22, 2026 (the "Record Date"). The dividend will be paid on or about August 3, 2026 to shareholders of record on Record Date. "This special dividend reflects the strength of our investment strategy and our commitment to returning value direct

Company announces name change to SRX Global in conjunction with transaction closingCompany's stock to remain trading on the NYSE American ("NYSE") under ticker symbol "SRXH" NORTH PALM BEACH, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company", or "SRX") today announced it has completed the acquisition of EMJ Crypto Technologies, Inc. ("EMJX") and is launching its new AI-driven platform strategy, which will focus on driving returns for shareholders through the allocation of capital into high-conviction operating companies and assets. In conjunction with the transaction closing, the Company has changed its legal name and branding to SRX Global Inc

NORTH PALM BEACH, Fla., June 08, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced acquiring 4.99% of Smartkem, Inc. (NASDAQ:SMTK), a leader in advanced materials, through a shelf take down. In conjunction with the 4.99% of equity, the Company has also purchased convertible preferred securities through a non-brokered private placement. Additional Information and Where to Find It In connection with the proposed transaction between the Company has filed with the SEC a Registration Statement on F

NORTH PALM BEACH, Fla., May 15, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced board approval to dividend 75% of profits from investment in Astro Investment XVII, an affiliate of Astro Capital and special purpose vehicle (SPV), with investments in SpaceX and other artificial intelligence and space companies. The Company recently announced an investment of greater than 10% of its investable capital in Astro Investment XVII and will return capital to shareholders upon wind down of the SPV. F

Q2 FY26 Marks Operational Inflection Point with Sequential 23% Revenue Growth and 44% Adjusted EBITDA Loss1 Improvement Strengthened Liquidity and Working Capital Position with Cash of $20.5 million as of Quarter End Active Cryptocurrency Strategy Outperformed Market by 6%, Reducing Losses by 23% Relative to Buy-and-Hold2 NORTH PALM BEACH, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company" or "SRX"), a pet health and wellness company, today announced its financial results for the fiscal second quarter 2026. "With a materially strengthened balance sheet, improved liquidity profile, and significantly improved working capital position, we entered

SRXH files Form S-4 with SEC in connection with EMJX merger  SRXH provides update on performance through mid-April with an approximate 3.5% gain in hedging pool, driven by EMJX's algorithm, and an approximate gain of 8% in its long treasury investment holdings NORTH PALM BEACH, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced acquiring shares in the open market of Compass Inc. and increasing its investment in Opendoor Technologies Inc. Further to additions to its portfolio,

+5.69% return for shareholders compares to -4.98% decline on the S&P 500 index SRx Health Board of Directors to consider implementing a quarterly dividend policy based on percentage of profits from portfolio NORTH PALM BEACH, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced returning +5.69% in March 2026 in its hedging pool driven by the EMJX artificial intelligence (AI) engine as compared to a decline of -4.98% on the S&P 500 index. Michael Young, Director of SRx Health, co

Executed Definitive Agreement to Acquire EMJ Crypto Technologies ("EMJX"), a "Gen 2" Digital-Asset Treasury Platform, Anticipated to Close in first half of Calendar 2026  Strengthened Balance Sheet, with $13.1 Million in Cash at Quarter End During and Subsequent to Quarter, Deployed $18 Million Into Bitcoin and Ethereum as part of Digital Treasury Strategy NORTH PALM BEACH, Fla., Feb. 13, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company" or "SRXH"), a pet health and wellness company, today announced its financial results for the fiscal first quarter 2026 for the three-month period ended December 31, 2025. "Q1 FY26 marked a pivotal reset for the Company," s

EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin1 Improved (9)%, a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions Inc. (NYSE:SRXH) (the "Company" or "SRx", previously known as "Better Choice"), a leading global health and wellness company, today announced its results for the first quarter ended March 31, 2025. "We have executed a digital first strategy in our domestic business and have implemented marketing investment shifts to grow brand awareness and discoverability," says Kent Cunningham, CEO of SRx. "We are focused on optimizing our port

TAMPA, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced it will host a conference call and webcast on Thursday, May 15, 2025, at 4:30 p.m. ET to discuss its financial results for the first quarter 2025 and provide a business update. Conference Call and Webcast Information:Event: First Quarter 2025 Financial Results Conference CallDate: Thursday, May 15, 2025Time: 4:30 p.m. Eastern TimeLive Call: 1-844-825-9789 or 1-412-317-5180Webcast:  https://srxhealth.com/events-and-presentations/ For interested individuals unable to join the conference call, the webcast replay of the call will